Jul 2026· Journal of Immunology· Vol 215· 0 citations
TL;DR
Through regulation of MHC I gene expression, PA-X decreases the rate of MHC I trafficking during infection, allowing the virus to replicate and spread, particularly in hosts with prior immunity to influenza A virus, and contributing to the continued success of this virus.
Abstract
Influenza A virus can evade detection by the adaptive immune system, as evidenced by low vaccine efficacy and reinfections during human challenge studies. Like all successful viruses, influenza A virus regulates host antiviral responses, and it encodes multiple immunomodulatory proteins for this purpose. One such viral protein, PA-X, is an endoribonuclease that suppresses host gene expression during infection. Here we investigate the impact of PA-X on MHC I antigen presentation, a key process for host detection of intracellular pathogens.
To investigate PA-X dependent changes during infection, we infected primary human donor air liquid interface (ALI) cultures of airway epithelial cells with wild type (WT) or PA-X deficient H3N2 influenza A virus. Using single cell RNA sequencing, we detected changes in gene expression of antigen processing and presentation. We then investigated surface and intracellular MHC I protein levels using flow cytometry and MHC I trafficking to the cell surface using an acid strip time course.
The influenza A viral protein PA-X significantly reduced expression of antigen processing and presentation genes in infected epithelial cells. Both surface and intracellular MHC I levels were significantly reduced in WT influenza-infected ALI cultures compared to mock-infected cultures or cultures infected with PA-X deficient virus. Furthermore, PA-X activity halved the rate of MHC I trafficking to the surface during infection.
Through regulation of MHC I gene expression, PA-X decreases the rate of MHC I trafficking during infection. This likely delays detection by antigen-specific T cells, allowing the virus to replicate and spread, particularly in hosts with prior immunity to influenza A virus, and contributing to the continued success of this virus. Future work will investigate the functional impacts of PA-X disruption of MHC I using immunopeptidomics and in vivo studies.
n/a
Viral Immunology (VIR)
This study develops a replication competent reporter IAV by fusing an 11-amino acid HiBiT tag into the nonstructural protein 1 (NS1) of the A/WSN/1933 (H1N1) backbone and identifies CIM53 as a potential host-directed adjunct therapy for severe IAV Infection.
T-cell immunity acts as a major defense system against controlling viral infections in vertebrates. During viral entry, innate immune cells degrade the viral proteins (antigens) and present them on their surface via Major Histocompatibility (MHC) proteins. T-cell receptors (TCRs) recognize these antigens/peptides prese...
Jaya Vasavi Pamidimukkala, Roshan Balaji, N. Bhatt et al.· 0 citations
Dengue virus rNS3pro immunization drives a robust expansion of multifaceted regulatory-like T-cell phenotypes, identifying the NS3 protease domain as a potential player in DENV immune evasion strategies.
V. Romero-Cruz, A. Ramos-Ligonio, Diana Lizzet Murrieta-León et al.· Acta Tropica· 0 citations
Introduction Vaccines targeting avian influenza virus A/H7N9 are poorly immunogenic. While the immune responses can be improved with oil-in-water emulsion adjuvants such as Adjuvant System 03 (AS03), the cellular mechanisms underpinning the adjuvant effect are incompletely characterized and poorly understood. Methods W...
C. B. Creech, Kristen J. Steenbergen, Casey E Gelber et al.· Frontiers in Immunology· 0 citations
Despite their shared origins within the arenavirus family, HB- 201 and HB-202 demonstrate distinct differences in early host-virus interaction, potentially resulting in shaping unique T cell responses.
Sarah Szaffich, Valentin Just, Natalija Cvetkovic et al.· Frontiers in Systems Biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.